RGC

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: NVS JNJ ABBV PFE MRK LLY BMY AZN-D NVO GSK

| Held by: ONEQ GXC GSID BKIE EEMO

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.01	Insider Own	88.68%	Shs Outstand	494.49M	Perf Week	-1.16%
Market Cap	14.32B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	55.99M	Perf Month	24.09%
Enterprise Value	14.31B	PEG	-	EPS next Q	-	Inst Own	0.11%	Short Float	1.48%	Perf Quarter	-10.34%
Income	-3.58M	P/S	-	EPS this Y	-	Inst Trans	-7.46%	Short Ratio	5.56	Perf Half Y	75.35%
Sales	0.00M	P/B	2945.07	EPS next Y	-	ROA	-50.50%	Short Interest	0.83M	Perf YTD	37.86%
Book/sh	0.01	P/C	2921.52	EPS next 5Y	-	ROE	-54.81%	52W High	83.60 -65.37%	Perf Year	3381.33%
Cash/sh	0.01	P/FCF	-	EPS past 3/5Y	22.39% -33.47%	ROIC	-70.39%	52W Low	0.80 3529.50%	Perf 3Y	4006.38%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.30% 11.18%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	17.24%	Oper. Margin	-	ATR (14)	2.64	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.39	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.93	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	7.39	EPS Q/Q	22.22%	SMA20	-1.74%	Beta	1.91	Target Price	-
Payout	-	Debt/Eq	0.11	Sales Q/Q	-	SMA50	6.42%	Rel Volume	0.43	Prev Close	29.05
Employees	10	LT Debt/Eq	0.05	Earnings	-	SMA200	40.37%	Avg Volume	149.28K	Price	28.95
IPO	Jul 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	63,868	Change	-0.34%

Apr-20-26 03:25PM	Taiwan Semiconductor Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks (InvestorPlace)
Feb-19-26 12:28PM	These 3 Growth Stocks Wont Be This Cheap Forever (24/7 Wall St.)
Feb-13-26 10:01AM	Softer-Than-Expected Inflation Sparks Rally In These 10 Stocks (Benzinga) +7.58%
Feb-01-26 02:31PM	UnitedHealth, Trade Desk, And Unity Are Among Top 10 Large Cap Losers Last Week (Jan. 26-Jan. 30): Are the Others in Your Portfolio? (Benzinga)
Jan-27-26 05:30AM	This $14 Billion Meme Stock Says It Is Developing a Herbal Remedy for Autism (The Wall Street Journal) +9.76%
12:31PM	Loading…
Jan-18-26 12:31PM	Trip.com, Regencell Bioscience, And Atlassian Are Among Top 10 Large Cap Losers Last Week (Jan. 12-Jan. 16): Are the Others in Your Portfolio? (Benzinga)
Jan-11-26 08:01AM	Sandisk, Bloom Energy, And Oklo Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio? (Benzinga)
Dec-11-25 08:24PM	Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank (Zacks)
Nov-24-25 09:05AM	This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock) (Motley Fool) -6.41%
Oct-22-25 05:47PM	The Best AI for Picking Stocks, Ranked by Performance (MarketBeat)
Oct-01-25 01:39PM	Regencell Bioscience Holdings Limited (RGC) Added to S&P Global BMI Index Amid Positive ADHD/ASD Trial Results (Insider Monkey)
Sep-04-25 01:01PM	Nasdaq Revamps Listing Rules for Small IPOs, Chinese Firms (Bloomberg) -7.09%
Sep-03-25 03:51AM	1 Magnificent Stock-Split Stock Up 157,000% Since Its IPO to Buy in September, and 1 to Absolutely Avoid (Motley Fool) +7.55%
Aug-04-25 03:51AM	1 Magnificent Stock-Split Stock to Buy Hand Over Fist in August and 1 to Absolutely Avoid (Motley Fool) +6.09%
Jul-31-25 11:31PM	Regencell (RGC) Completes 38-for-1 Stock Split (Insider Monkey) -8.52%
03:51PM	Loading…
Jul-17-25 03:51PM	Regencell Bioscience (RGC) Insanely Up Over 11,000% in H1 (Insider Monkey)
Jul-08-25 02:26PM	Regencell Bioscience (RGC) Nosedives 19.8% on Profit-Taking (Insider Monkey)
Jul-07-25 10:34AM	Regencell Bioscience Stock Volatility Continues Monday (Investopedia) -19.83%
Jul-01-25 03:51AM	1 Magnificent Stock-Split Stock to Buy Hand Over Fist in July and 1 to Completely Avoid (Motley Fool) -14.32%
Jun-30-25 04:03PM	Trading in risky penny stocks is booming. Why it could be a sign of trouble ahead for the market. (MarketWatch)
Jun-27-25 12:05PM	Regencell's 82,000% Surge: The $33 Billion Stock Rally That Nobody Can Explain (GuruFocus.com) -13.82%
05:18AM	Mystery $33 Billion Medicine Fortune Collapses in Days (Bloomberg)
Jun-20-25 03:06AM	Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode... It's Just a Matter of Time (Motley Fool) -40.00%
Jun-17-25 12:43PM	The 46,000% Biotech Rocket: How a No-Revenue Stock Hit $30 Billion (GuruFocus.com) +30.00%
12:25PM	Silver's rise, Reddit's AI ad tools, Regencell Bioscience surges (Yahoo Finance Video)
Jun-16-25 04:30PM	Herbal Medicine Stock With No Sales Rallies 64,000% (Bloomberg) +283.13%
11:00AM	Regencell Bioscience Stock Skyrockets as 38-to-1 Split Takes Effect (Investopedia)
Apr-30-25 06:01AM	Why Regencell Bioscience Holdings Limited (RGC) is Surging in 2025 (Insider Monkey) +89.87%
Mar-22-25 11:00AM	Investors To Focus On PCE Price Index Print As Cintas, Lululemon To Report Earnings (SeekingAlpha)
Mar-21-25 06:35AM	Why Regencell Bioscience Holdings Ltd. (RGC) Surged On Thursday? (InsiderMonkey) +30.29%
07:28AM	Loading…
Mar-17-25 07:28AM	Why Regencell Bioscience Holdings Limited (RGC) Soared Last Week? (Insider Monkey) +46.59%
Jul-23-24 04:02PM	What Is Going on With Regencell Bioscience (RGC) Stock Today? (InvestorPlace) +343.92% -9.76%
Nov-15-23 04:31PM	15 Developed Countries with Lowest Autism Rates (Insider Monkey) +11.11%
Jul-31-23 08:15AM	With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future (Simply Wall St.)
Apr-03-23 07:25AM	One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 0.5% in the previous year (Simply Wall St.)
Feb-21-23 06:36AM	With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future (Simply Wall St.) -5.99%
Nov-21-22 06:49AM	Companies Like Regencell Bioscience Holdings (NASDAQ:RGC) Are In A Position To Invest In Growth (Simply Wall St.)
Nov-15-22 07:55AM	RGC: Forging a New Approach to ADHD and ASD (Zacks Small Cap Research)
Oct-25-22 06:55AM	One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 1.4% in the previous year (Simply Wall St.)
Sep-14-22 06:55AM	81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) is owned by insiders, and they've been buying recently (Simply Wall St.)
Sep-12-22 09:15AM	Regencell Biosciences Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial (Business Wire)
Jun-20-22 05:27AM	RGC: CEO Figuratively Putting His Money Where His Mouth Is (Zacks Small Cap Research)
May-24-22 05:46AM	RGC: Second investigational study of RGC-COV19 replicates results of earlier trial in eliminating COVID-19 symptoms. (Zacks Small Cap Research)
May-18-22 08:05AM	Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period (Business Wire)
06:14AM	The Founder of Regencell Bioscience Holdings Limited (NASDAQ:RGC), Yat-Gai Au, Just Bought A Few More Shares (Simply Wall St.)
May-16-22 08:56AM	Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO (Business Wire)
Apr-14-22 10:03AM	RGC: Regencell Bioscience - Investigational Liquid-Formula RGC-COV19 Shows Promise in Eliminating COVID-19 Symptoms (Zacks Small Cap Research)
Apr-07-22 06:09AM	What Is The Ownership Structure Like For Regencell Bioscience Holdings Limited (NASDAQ:RGC)? (Simply Wall St.) +9.34%
Mar-01-22 08:30AM	Regencell Describes Their Traditional Chinese Medicine ("TCM") Treatments and Recent Efficacy Trial Results in New Video Interview on SNN Network (ACCESSWIRE)
Feb-17-22 11:40AM	Regencell Bioscience's COVID-19 Candidate Shows Encouraging Action On Mild To Moderate Symptoms (Benzinga) +14.45%
Feb-16-22 08:42PM	Regencell Biosciences Investigational Liquid-Formula RGC-COV19TM Shows Effectiveness Through Its Enrolled Patients in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-day Treatment Period in its EARTH Efficacy Trial (Business Wire)
Dec-13-21 08:35AM	Regencell Bioscience Holdings Limited Appoints Dr. William Wing-Yan Lo, JP to its Board of Directors (Business Wire)
Nov-22-21 08:15AM	Regencell Bioscience Holdings Limited Announces Over $1 Million Ordinary Share Purchase by CEO (Business Wire)
08:00AM	Regencell Bioscience Holdings Limited Included in the MSCI World Micro Cap Index (Business Wire)
Nov-02-21 04:00AM	RGC: Traditional Chinese Medicine Approach for treatment of neurodevelopmental conditions (Zacks Small Cap Research)
Oct-19-21 11:44AM	Do Institutions Own Regencell Bioscience Holdings Limited (NASDAQ:RGC) Shares? (Simply Wall St.)
Sep-10-21 06:18AM	Cineworld to pay £122m to dissenting shareholders after Regal takeover (The Independent)
02:42AM	UPDATE 1-Cineworld pays $170 mln to Regal investors unhappy with 2017 buyout (Reuters)
Sep-02-21 08:00AM	Regencell Bioscience Holdings Limited Establishes a Joint Venture to Offer COVID Treatment (Business Wire)
Aug-20-21 08:00AM	Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriters Over-Allotment Option (Business Wire) +204.13%
Aug-05-21 08:00AM	Regencell Bioscience Holdings Limited Releases CEO Letter to Shareholders (Business Wire) +6.29%
Jul-20-21 04:05PM	Regencell Bioscience Holdings Limited Announces Closing of Initial Public Offering (Business Wire)
Jul-16-21 11:43AM	Regencell Bioscience Holdings Limited Announces Pricing of Approximately $21.9 Million Initial Public Offering (Business Wire)

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Regencell Bioscience Holdings Ltd

Upgrade your Finviz experience